ONCOSYNE AS
926191942ActiveDeveloping cancer treatments using patient-derived 3D tumoroid models.
Översikt
- 6
- Anställda
- 4.4milj NOK
- Omsättning
- 2020
- Grundat
Nyckelbeslutsfattare
Jarle Bruun
CEO and co-founder
Aarti Kapoor
Director, Strategic Partnerships
Peter W. Eide
CTO and co-founder
Christer Anker Andreassen
Product developer
+8 fler kontakter i Funnelfeedr
Beskrivning
Oncosyne operates at the forefront of precision oncology, utilizing its proprietary iCAN tumoroid platform. This platform creates living, patient-derived 3D tumor models that accurately mimic the characteristics of a patient's original cancer. For the pharmaceutical industry, Oncosyne offers compreh...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Okänt
Beslutsfattare
12 kontakter i FunnelfeedrJarle Bruun
CEO and co-founder
Aarti Kapoor
Director, Strategic Partnerships
Peter W. Eide
CTO and co-founder
Christer Anker Andreassen
Product developer
Övriga kontakter
Øyvind Bruland
Clinical advisor
Åke Andrén-Sandberg
Clinical advisor
Tine Norman Alver
Laboratory scientist
Janne Nestvold
Business advisor
+4 fler kontakter i Funnelfeedr
Liknande företag
20 liknande företag i FunnelfeedrDOMORE DIAGNOSTICS AS
9 anställdaDeveloping AI pathology tests for personalized cancer treatment decisions.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
OSLO SCIENCE HUB AS
Accelerating cancer treatment development through collaboration and innovation.
RAB DIAGNOSTICS AS
Developing predictive biomarkers for optimizing Antibody-Drug Conjugate therapies.
HEMISPHERIAN AS
5 anställdaDeveloping novel small molecule drugs targeting TET2 for aggressive cancers.
Utforska mer
Frågor om ONCOSYNE AS
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo